email article
Despite an arsenal of highly effective injectable vaccines, drugmakers are looking into products that will be easier to store, transport, and administer in the global crisis particularly, intranasal vaccines.
Could these vaccines also hold an advantage when it comes to blocking transmission? While more data has suggested the vaccines authorized in the U.S. cut transmission, some experts have argued that intranasal vaccines may do an even better job of this.
MedPage Today surveyed the global landscape of intranasal vaccines in development, the majority of which are in early stages.
Rationale for COVID-19 Mucosal Vaccines
The mucosal immune system represents the body s first line of defense against outside pathogens at surfaces like the nose, lungs, mouth, eyes, and GI tract. Because the nasopharynx is the primary entry point for SARS-CoV-2, targeting the nasal cavity could be one of the best lines of defense for vaccines, according to Michael Russell, PhD,
Serum Institute seeks approval to conduct trial for Novavax COVID-19 vaccine
Last year in September, Novavax had announced its deal with Serum Institute in order to produce 2 billion doses of COVID-19 vaccines
BusinessToday.In | January 29, 2021 | Updated 16:49 IST
Novavax s protein-based coronavirus vaccine was 89.3 per cent effective in preventing coronavirus in a trial conducted in the UK
After successfully manufacturing the University of Oxford-AstraZeneca s Covishield vaccine in India, Serum Institute of India (SII) has now applied to India s drug controller to conduct a trial of Novavax Inc s COVID-19 vaccine. Serum Institute s CEO Adar Poonwalla told news agency Reuters that he is expecting a decision on the Indian trial on Novavax s vaccine soon.
Jharkhand to get 1.62 lakh doses of Covid vaccine on Wednesday, 129 centres set up for distribution
Jharkhand to get 1.62 lakh doses of Covid vaccine on Wednesday, 129 centres set up for distribution
Jharkhand will receive the first consignment of around 1,62,000 doses of the Covid-19 vaccine on Wednesday.
advertisement
UPDATED: January 12, 2021 23:36 IST
The Jharkhand government expects to receive its first consignment of Covishield vaccines tomorrow (Photo: Reuters/Representational image)
Jharkhand will receive the first consignment of around 1,62,000 doses of the Covid-19 vaccine on Wednesday. The flight carrying the vaccine will reach Birsa Munda airport in Ranchi by 2 pm Wednesday following which doses of the vaccine will be delivered at 129 centres.